The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors

Hepatitis C virus (HCV) infects over 170 million people worldwide and is the leading cause of chronic liver diseases, including cirrhosis, liver failure, and liver cancer. Available antiviral therapies cause severe side effects and are effective only for a subset of patients, though treatment outcom...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Romano, Keith P., Ali, Akbar, Aydin, Cihan, Soumana, Djade, Özen, Ayşegül, Deveau, Laura M., Silver, Casey, Cao, Hong, Newton, Alicia, Petropoulos, Christos J., Huang, Wei, Schiffer, Celia A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2012
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3406087/
https://ncbi.nlm.nih.gov/pubmed/22910833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.ppat.1002832
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller